Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GEORGOULIAS, Vassilis")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 84

  • Page / 4
Export

Selection :

  • and

Docetaxel (Taxotere) in the treatment of non-small cell lung cancerGEORGOULIAS, Vassilis.Current medicinal chemistry. 2002, Vol 9, Num 8, pp 869-877, issn 0929-8673Article

Is there a standard regimen for first-line treatment of advanced/metastatic Non-Small-Cell Lung Cancer? What has meta-analyses contributed to today's standard of carePALLIS, Athanasios G; GEORGOULIAS, Vassilis.Lung cancer. 2012, Vol 75, Num 3, pp 269-274, issn 0169-5002, 6 p.Article

Micrometastatic disease in breast cancer : Clinical implicationsIGNATIADIS, Michail; GEORGOULIAS, Vassilis; MAVROUDIS, Dimitris et al.European journal of cancer (1990). 2008, Vol 44, Num 18, pp 2726-2736, issn 0959-8049, 11 p.Article

Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel―mediated anti-tumor effectSPILIOTAKI, Maria; MARKOMANOLAKI, Haris; MELA, Marilena et al.Lung cancer. 2011, Vol 73, Num 2, pp 158-165, issn 0169-5002, 8 p.Article

Fulvestrant in the treatment of advanced breast cancer: A systematic review and meta-analysis of randomized controlled trialsVALACHIS, Antonis; MAURI, Davide; POLYZOS, Nikolaos P et al.Critical reviews in oncology/hematology. 2010, Vol 73, Num 3, pp 220-227, issn 1040-8428, 8 p.Article

Present Treatment and Future Expectations in Advanced Pancreatic CancerSTATHOPOULOS, George P; ANDROULAKIS, Nikos; SOUGLAKOS, John et al.Anticancer research. 2008, Vol 28, Num 2B, pp 1303-1308, issn 0250-7005, 6 p.Article

Excision-repair-cross-complement-1 protein as a prognostic factor in patients with advanced non-small cell lung cancer treated with platinum-based first-line chemotherapyVASSALOU, Helen; STATHOPOULOS, Efstathios; FIOLITAKI, Georgia et al.Lung cancer. 2013, Vol 82, Num 2, pp 324-329, issn 0169-5002, 6 p.Article

Prognostic Value of Mature MicroRNA-21 and MicroRNA-205 Overexpression in Non-Small Cell Lung Cancer by Quantitative Real-Time RT-PCRMARKOU, Athina; TSAROUCHA, Emily G; KAKLAMANIS, Loukas et al.Clinical chemistry (Baltimore, Md.). 2008, Vol 54, Num 10, pp 1696-1704, issn 0009-9147, 9 p.Article

Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinibKALYKAKI, Antonia; AGELAKI, Sofia; KALLERGI, Galatea et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 4, pp 685-693, issn 0344-5704, 9 p.Article

Second-line chemotherapy in relapsing or refractory patients with non-small cell lung cancerGEORGOULIAS, Vassilis A.Lung cancer. 2002, Vol 38, pp S61-S66, issn 0169-5002, SUP3Article

A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLCPALLIS, Athanasios G; CHANDRINOS, Vassilis; PAVLAKOU, Georgia et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 6, pp 1239-1245, issn 0344-5704, 7 p.Article

Phase III Study Comparing Sequential Versus Alternate Administration of Cisplatin-Etoposide and Topotecan as First-line Treatment in Small Cell Lung CancerBAKA, Sophia; AGELAKI, Sophia; ANDROULAKIS, Nikolaos et al.Anticancer research. 2010, Vol 30, Num 7, pp 3031-3038, issn 0250-7005, 8 p.Article

Continuous Administration of Daily Low-Dose Temozolomide in Pretreated Patients with Advanced Non-Small Cell Lung Cancer : A Phase II StudyKOUROUSSIS, Charalambos; VAMVAKAS, Lambros; VARDAKIS, Nikolaos et al.Oncology. 2009, Vol 76, Num 2, pp 112-117, issn 0030-2414, 6 p.Article

A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancerPALLIS, Athanasios G; AGELIDOU, Athina; KENTEPOZIDIS, Nikolaos et al.Lung cancer. 2006, Vol 52, Num 2, pp 165-171, issn 0169-5002, 7 p.Article

A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancerIGNATIADIS, Michail; POLYZOS, Aris; STATHOPOULOS, George P et al.Oncology. 2006, Vol 71, Num 3-4, pp 159-163, issn 0030-2414, 5 p.Article

Micromolar taxol, with or without hyperthermia, induces mitotic catastrophe and cell necrosis in HeLa cellsMICHALAKIS, John; GEORGATOS, Spyros D; ROMANOS, John et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, Num 6, pp 615-622, issn 0344-5704, 8 p.Article

Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III randomized trialGEORGOULIAS, Vassilis; ARDAVANIS, Alexandros; POLYZOS, Aris et al.Journal of clinical oncology. 2005, Vol 23, Num 13, pp 2937-2945, issn 0732-183X, 9 p.Article

Nonneutropenic febrile episodes associated with docetaxel-based chemotherapy in patients with solid tumorsSOUGLAKOS, John; KOTSAKIS, Athanaslos; KOUROUSSIS, Charalambos et al.Cancer. 2002, Vol 95, Num 6, pp 1326-1333, issn 0008-543XArticle

A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancerSARIDAKI, Zacharenia; MALAMOS, Nikolaos; KOURAKOS, Panagiotis et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 1, pp 35-42, issn 0344-5704, 8 p.Article

Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)BOUKOVINAS, Ioannis; ANDROULAKIS, Nikolaos; KOSTAKOPOULOS, Athanasios et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 2, pp 351-356, issn 0344-5704, 6 p.Article

A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancerKOTSAKIS, Athanasios; AGELAKI, Sophia; GEORGOULIAS, Vassilis et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 2, pp 415-422, issn 0344-5704, 8 p.Article

A multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancerXENIDIS, Nikolaos; VARDAKIS, Nikolaos; VARTHALITIS, Loannis et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 1, pp 63-68, issn 0344-5704, 6 p.Article

Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumabPOLYZOS, Aris; KALBAKIS, Kostas; MAVROUDIS, Dimitris et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 1, pp 217-223, issn 0344-5704, 7 p.Article

A Retrospective Analysis of Non-platinum-based First- and Second-line Chemotherapy in Patients with Advanced Non-small Cell Lung CancerKOTSAKIS, Athanasios; HATZIDAKI, Dora; AGELAKI, Sophia et al.Anticancer research. 2010, Vol 30, Num 10, pp 4335-4342, issn 0250-7005, 8 p.Article

Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptideBOLONAKI, Irini; KOTSAKIS, Athanassios; CORDOPATIS, Paul et al.Journal of clinical oncology. 2007, Vol 25, Num 19, pp 2727-2734, issn 0732-183X, 8 p.Article

  • Page / 4